Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer
2006 ◽
Vol 26
(18)
◽
pp. 2621-2634
◽
S Zhong
◽
C R Fields
◽
N Su
◽
Y-X Pan
◽
K D Robertson
2018 ◽
Vol 13
(10)
◽
pp. e0203155
◽
Juan Wang
◽
Yong Duan
◽
Qing-He Meng
◽
Rong Gong
◽
Chong Guo
◽
...
2009 ◽
Vol 64
(1)
◽
pp. 86-91
◽
Yasumitsu Moriya
◽
Akira Iyoda
◽
Yasuhiro Kasai
◽
Takashi Sugimoto
◽
Junya Hashida
◽
...
2006 ◽
Vol 15
(11)
◽
pp. 2063-2068
◽
2018 ◽
Vol 10
(8)
◽
pp. 1103-1119
◽
Mariya A Smetanina
◽
Alexander E Kel
◽
Ksenia S Sevost'ianova
◽
Igor V Maiborodin
◽
Andrey I Shevela
◽
...
R. Battafarano
◽
J. Lewis
◽
J. Ritter
◽
B. Meyers
◽
J. Cooper
◽
...
2010 ◽
Vol 10
(1)
◽
pp. 2
◽
Takashi Watanabe
◽
Tomohiro Miura
◽
Yusuke Degawa
◽
Yuna Fujita
◽
Masaaki Inoue
◽
...
2005 ◽
Vol 49
◽
pp. S143-S144
S. Saviozzi
◽
M. Volante
◽
M. Lo Iacono
◽
M. Papotti
◽
G. Scagliotti
◽
...
2018 ◽
Vol 31
(6)
◽
pp. 947-955
◽
Won-Chul Lee
◽
Lixia Diao
◽
Jing Wang
◽
Jianhua Zhang
◽
Emily B. Roarty
◽
...
2003 ◽
Vol 35
(2)
◽
pp. 154-160
◽
Mee Sook Roh
◽
Hyuk Chan Kwon
◽
Jin Sook Jeong
◽
Dae Cheol Kim
◽
Choon Hee Son
◽
...
Close
Export Citation Format
Close
Share Document
Close